Gabriel
Well-Known Member
I think Pfizer, AZ, J&J and others have all got production facilities in Belgium. Looking to the future, it might be prudent to have extra facilities and capacity in other countries as well, as it looks like a security weak spot if one such area were attacked.It does seem that Belgium has dominated production of vaccines with even the US supplies of the Pfizer jabs being flown in from Belgium. I see our Government invested in vaccine manufacturing in Oxfordshire and Essex but I don’t know if these sites are up and running and producing the Oxford / AZ vaccine.
Government to develop £100m Covid-19 vaccine manufacturing centre
New sites in Braintree and Oxford will open in 2021, with a rapid deployment facility due this summerwww.theguardian.com
I understand the MHRA and EMA Frameworks are similar so I guess there is case for the EMA fast tracking approvals but they probably consider themselves to be working fast (especially in comparison with non pandemic timescales).
I agree with you that many of us were expecting vaccines to be stockpiled leading up to regulatory approval and it hasn’t been explained well why this hasn’t been the case. I know there will probably be good reasons but it is a frustrating when areas are having to slow down vaccine roll out due to lack of availability of vaccines.
I don’t know if it was ever feasible to produce the Pfizer vaccine and stockpile it, but I believe the J&J one has been stockpiled, though not in the quantities that will be required.
Again, looking to the future, I can see a case for manufacturing facilities, both in the U.K. and the EU to be somehow ‘nationalised’ so that such problems can be averted. Many lessons to be learned.